Atopic Dermatitis Treatment Targets Defined

• by Kerri Miller

• April 15, 2026

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

• by Andrea Surnit

• May 20, 2026

• 4 min

Do antihistamines help atopic dermatitis?

First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.

• by Kathryn Wighton

• August 31, 2026

• 4 min

Letter to the Editor Regarding “Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis”

• by Kim Rand, Kurt Gebauer, Yousef Binamer, Yung-Tsu Cho, Manny Papadimitropoulos, Chao Yang, Helena Agell, Bülent Akmaz, Lucia Seminario-Vidal

• June 26, 2026